PRINCETON, N.J., April 13, 2021 /PRNewswire/ -- Quartesian, a multinational Clinical Research Organization (CRO) serving the biopharmaceutical and medical device industries, today announced a multi-year agreement with a leading portfolio medical technology company. Under the agreement Quartesian is providing Electronic Data Capture (EDC) programming using Medidata Rave EDC, full data management, and SAS statistical services in support of several franchises. ...Full story available on Benzinga.com